Key financial ranges
Market cap · USD equivalent−∞—+∞
P/E ratio−∞—+∞
Annual revenue · USD equivalent−∞—+∞
Revenue growth−∞—+∞
3,061–3,080 of 6,553
CompanyMarket capP/ERevenueRev. growthNet incomeCashDebtAI value
XRNChiron Real Estate Inc.$540.8M10.0×$526K+42.2%-$6.88M$10.66M$13.39MAI pending
ARKOARKO Corp.$541.3M63.6×$7.64B-12.5%$22.74M$245.56M$2.33BUndervalued
EBFEnnis, Inc.$541.38M12.8×$392.4M-0.6%$42.63M$49.08M$8.05MAI pending
OVIDOvid Therapeutics Inc.$541.95M—$7.25M+1,181.3%-$17.41M$11.33M$12.72MAI pending
MOVMovado Group Inc$542.61M18.8×$671.31M+2.7%$26.55M$211.61M$68.11MAI pending
IMSRTerrestrial Energy Inc.$542.92M—$248.36K—-$11.49M$130.74M$3.88MAI pending
ARTVArtiva Biotherapeutics, Inc.$546.35M—$0-100.0%-$83.87M$301.45M$9.85MAI pending
IPIIntrepid Potash, Inc.$547.08M41.1×$298.33M+17.1%$11.19M$184.99M$3.24MAI pending
BDNBrandywine Realty Trust$547.3M—$484.45M-4.2%-$178.25M$36.2M$2.65BAI pending
QUADQuad/Graphics, Inc.$548.47M17.0×$2.42B-9.4%$27M$7M$503.4MAI pending
ILPTIndustrial Logistics Properties Trust$549.32M—$448.85M+1.5%-$66.19M$135.33M$4.19BAI pending
MBUUMalibu Boats, Inc.$549.39M376.8×$914.59M+13.3%$1.65M$74.42M$176.75MAI pending
CAPRCapricor Therapeutics, Inc.$549.41M—$0-100.0%-$105.04M$20.94M$91.05MAI pending
LAESSEALSQ Corp$553.81M—$18.25M+66.2%-$34.19M$417.66M$8MAI pending
CMDBCostamare Bulkers Holdings Ltd$554.2M—$597.22M—-$37.35M$211.85M$194.75MAI pending
SPRYARS Pharmaceuticals, Inc.$554.42M—$84.28M-5.5%-$171.3M$8.16M$96.68MAI pending
YORWYork Water Co$555.02M21.4×$77.02M+3.4%$20.06M$555K$189.7MAI pending
RBTKZhen Ding Resources Inc.$555.95M—$648.55K—-$1.19M$25.97K$154.5KOvervalued
HBCPHome Bancorp, Inc.$556.27M11.8×$148.72M+10.3%$46.06M$188.22M$9.58MAI pending
FACFactorial Energy Inc.$557.59M————$112.83M$7.88MAI pending